{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:13:56Z","timestamp":1790284436271,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Huai'an Municipal Health Commission","award":["HAP202302"],"award-info":[{"award-number":["HAP202302"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15089-6","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T13:13:25Z","timestamp":1761570805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The prognostic value of POD24 for multiple myeloma: a comprehensive analysis based on traditional statistics and machine learning"],"prefix":"10.1186","volume":"25","author":[{"given":"Quane","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuni","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuye","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengmei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"issue":"9","key":"15089_CR1","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/ajh.27422","volume":"99","author":"SV Rajkumar","year":"2024","unstructured":"Rajkumar SV. Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2024;99(9):1802\u201324.","journal-title":"Am J Hematol"},{"issue":"5","key":"15089_CR2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/leu.2013.313","volume":"28","author":"SK Kumar","year":"2014","unstructured":"Kumar SK, Dispenzieri A, Lacy MQ, et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014;28(5):1122\u20138.","journal-title":"Leukemia"},{"issue":"1","key":"15089_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/bjh.15504","volume":"183","author":"R Oostvogels","year":"2018","unstructured":"Oostvogels R, Jak M, Raymakers R, Mous R, Minnema MC. Efficacy of retreatment with Immunomodulatory drugs and proteasome inhibitors following daratumumab monotherapy in relapsed and refractory multiple myeloma patients. Br J Haematol. 2018;183(1):60\u20137.","journal-title":"Br J Haematol"},{"issue":"4","key":"15089_CR4","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3390\/cells11040606","volume":"11","author":"S Mor\u00e8","year":"2022","unstructured":"Mor\u00e8 S, Corvatta L, Manieri VM, et al. Autologous stem cell transplantation in multiple myeloma: where are we and where do we want to go. Cells. 2022;11(4):606.","journal-title":"Cells"},{"key":"15089_CR5","doi-asserted-by":"publisher","first-page":"101100","DOI":"10.1016\/j.blre.2023.101100","volume":"61","author":"D Kegyes","year":"2023","unstructured":"Kegyes D, Gulei D, Drula R, et al. Proteasome Inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma. Blood Rev. 2023;61:101100.","journal-title":"Blood Rev"},{"issue":"4","key":"15089_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.bbmt.2018.12.141","volume":"25","author":"S Gopalakrishnan","year":"2019","unstructured":"Gopalakrishnan S, D\u2019Souza A, Scott E, et al. Revised international staging system is predictive and prognostic for early relapse (<\u200924 months) after autologous transplantation for newly diagnosed multiple myeloma. Biol Blood Marrow Transpl. 2019;25(4):683\u20138.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"9","key":"15089_CR7","doi-asserted-by":"publisher","first-page":"e480","DOI":"10.3324\/haematol.2019.236588","volume":"105","author":"J Corre","year":"2020","unstructured":"Corre J, Montes L, Martin E, et al. Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk. Haematologica. 2020;105(9):e480\u2013483.","journal-title":"Haematologica"},{"issue":"3","key":"15089_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/bjh.16793","volume":"193","author":"C Bygrave","year":"2021","unstructured":"Bygrave C, Pawlyn C, Davies F, et al. Early relapse after high-dose Melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high-risk disease in multiple myeloma. Br J Haematol. 2021;193(3):551\u20135.","journal-title":"Br J Haematol"},{"issue":"13","key":"15089_CR9","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1158\/1078-0432.CCR-21-0134","volume":"27","author":"GM Zaccaria","year":"2021","unstructured":"Zaccaria GM, Bertamini L, Petrucci MT, et al. Development and validation of a simplified score to predict early relapse in newly diagnosed multiple myeloma in a pooled dataset of 2,190 patients. Clin Cancer Res. 2021;27(13):3695\u2013703.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"15089_CR10","doi-asserted-by":"publisher","first-page":"22861","DOI":"10.1038\/s41598-024-73822-w","volume":"14","author":"Y Cao","year":"2024","unstructured":"Cao Y, Gong Y, Wang Q, Xia J, Zhou X, Sun C. Progression of disease within 24 months (POD24) in multiple myeloma implicates poor prognosis and limitations of current prediction models for POD24. Sci Rep. 2024;14(1):22861.","journal-title":"Sci Rep"},{"issue":"3","key":"15089_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/cncr.35056","volume":"130","author":"W Yan","year":"2024","unstructured":"Yan W, Xu J, Fan H, et al. Early relapse within 18 months is a powerful dynamic predictor for prognosis and could revise static risk distribution in multiple myeloma. Cancer. 2024;130(3):421\u201332.","journal-title":"Cancer"},{"issue":"13","key":"15089_CR12","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/NEJMp1606181","volume":"375","author":"Z Obermeyer","year":"2016","unstructured":"Obermeyer Z, Emanuel EJ. Predicting the Future - Big Data, machine Learning, and clinical medicine. N Engl J Med. 2016;375(13):1216\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"15089_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40364-024-00716-4","volume":"13","author":"J Zha","year":"2025","unstructured":"Zha J, Chen Q, Zhang W, et al. A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphoma. Biomark Res. 2025;13(1):2.","journal-title":"Biomark Res"},{"issue":"1","key":"15089_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41746-024-01189-3","volume":"7","author":"Z Hussain","year":"2024","unstructured":"Hussain Z, De Brouwer E, Boiarsky R, et al. Joint AI-driven event prediction and longitudinal modeling in newly diagnosed and relapsed multiple myeloma. NPJ Digit Med. 2024;7(1):200.","journal-title":"NPJ Digit Med"},{"issue":"1","key":"15089_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.6004\/jnccn.2022.0002","volume":"20","author":"NS Callander","year":"2022","unstructured":"Callander NS, Baljevic M, Adekola K, et al. NCCN Guidelines\u00ae insights: multiple Myeloma, version 3.2022. J Natl Compr Canc Netw. 2022;20(1):8\u201319.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"15089_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13045-021-01162-7","volume":"14","author":"CT Wallington-Beddoe","year":"2021","unstructured":"Wallington-Beddoe CT, Mynott RL. Prognostic and predictive biomarker developments in multiple myeloma. J Hematol Oncol. 2021;14(1):151.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"15089_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1023\/A:1022627411411","volume":"20","author":"C Cortes","year":"1995","unstructured":"Cortes C, Vapnik V, Support-Vector, Networks. Mach Learn. 1995;20(3):273\u201397.","journal-title":"Mach Learn"},{"issue":"1","key":"15089_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/A:1022643204877","volume":"1","author":"JR Quinlan","year":"1986","unstructured":"Quinlan JR. Induction of decision trees. Mach Learn. 1986;1(1):81\u2013106.","journal-title":"Mach Learn"},{"key":"15089_CR19","doi-asserted-by":"crossref","unstructured":"Loh WY. Classification and regression trees. Wiley Interdisciplinary Reviews: Data Mining and Knowledge Discovery. 2011.","DOI":"10.1002\/widm.8"},{"key":"15089_CR20","doi-asserted-by":"crossref","unstructured":"Breiman. Random forests. Mach learn. 2001;45(1)(-): 5\u201332.","DOI":"10.1023\/A:1010933404324"},{"issue":"1","key":"15089_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10994-006-6226-1","volume":"63","author":"P Geurts","year":"2006","unstructured":"Geurts P, Ernst D, Wehenkel L. Extremely randomized trees. Mach Learn. 2006;63(1):3\u201342.","journal-title":"Mach Learn"},{"issue":"5","key":"15089_CR22","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1214\/aos\/1013203451","volume":"29","author":"JH Friedman","year":"2001","unstructured":"Friedman JH. Greedy function approximation: A gradient boosting machine. Ann Stat. 2001;29(5):1189\u2013232.","journal-title":"Ann Stat"},{"key":"15089_CR23","unstructured":"Meng Q. LightGBM: A Highly Efficient Gradient Boosting Decision Tree. 2017."},{"key":"15089_CR24","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C. XGBoost: A Scalable Tree Boosting System. ACM. 2016.","DOI":"10.1145\/2939672.2939785"},{"key":"15089_CR25","doi-asserted-by":"publisher","unstructured":"Cover T, Hart P. Nearest neighbor pattern classification. IEEE transactions on information theory. 1967;13(1):21\u20137. https:\/\/doi.org\/10.1109\/TIT.1967.1053964.","DOI":"10.1109\/TIT.1967.1053964"},{"issue":"6088","key":"15089_CR26","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/323533a0","volume":"323","author":"DE Rumelhart","year":"1986","unstructured":"Rumelhart DE, Hinton GE, Williams RJ. Learning representations by back propagating errors. Nature. 1986;323(6088):533\u20136.","journal-title":"Nature"},{"issue":"11","key":"15089_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/14786440109462720","volume":"2","author":"K Pearson","year":"1901","unstructured":"Pearson K. Liii. On lines and planes of closest fit to systems of points in space. Philos Mag. 1901;2(11):559\u201372.","journal-title":"Philos Mag"},{"issue":"7","key":"15089_CR28","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1037\/h0070888","volume":"24","author":"H Hotelling","year":"1933","unstructured":"Hotelling H. Analysis of a complex of statistical variables in principal components. J Educ Psychol. 1933;24(7):498\u2013520.","journal-title":"J Educ Psychol"},{"key":"15089_CR29","doi-asserted-by":"publisher","unstructured":"Lundberg S, Lee SI. A unified approach to interpreting model predictions. Adv Neural Inf Process Syst. 2017;30:4768\u201377. https:\/\/doi.org\/10.5555\/3295222.3295230.","DOI":"10.5555\/3295222.3295230"},{"issue":"3","key":"15089_CR30","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/leu.2008.336","volume":"23","author":"GD Roodman","year":"2009","unstructured":"Roodman GD. Pathogenesis of myeloma bone disease. Leukemia. 2009;23(3):435\u201341.","journal-title":"Leukemia"},{"issue":"6","key":"15089_CR31","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1158\/1078-0432.CCR-10-1804","volume":"17","author":"N Raje","year":"2011","unstructured":"Raje N, Roodman GD. Advances in the biology and treatment of bone disease in multiple myeloma. Clin Cancer Res. 2011;17(6):1278\u201386.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"15089_CR32","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538\u201348.","journal-title":"Lancet Oncol"},{"issue":"6","key":"15089_CR33","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1182\/blood-2018-03-840132","volume":"132","author":"BA Walker","year":"2018","unstructured":"Walker BA, Mavrommatis K, Wardell CP, et al. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma. Blood. 2018;132(6):587\u201397.","journal-title":"Blood"},{"issue":"15","key":"15089_CR34","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"PR Greipp","year":"2005","unstructured":"Greipp PR, San Miguel J, Durie BG, et al. International staging system for multiple myeloma. J Clin Oncol. 2005;23(15):3412\u201320.","journal-title":"J Clin Oncol"},{"issue":"1","key":"15089_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1470-2045(18)30687-9","volume":"20","author":"GH Jackson","year":"2019","unstructured":"Jackson GH, Davies FE, Pawlyn C, et al. Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2019;20(1):57\u201373.","journal-title":"Lancet Oncol"},{"key":"15089_CR36","doi-asserted-by":"crossref","unstructured":"Corre J, Vincent L, Moreau P et al. Daratumumab-Bortezomib-Thalidomide-Dexamethasone for Newly Diagnosed Myeloma: CASSIOPEIA Minimal Residual Disease Results. Blood. 2025: blood.2024027620 [pii].","DOI":"10.1182\/blood.2024027620"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15089-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15089-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15089-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T13:13:32Z","timestamp":1761570812000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15089-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15089"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15089-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"20 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Huai\u2019an No.1 People\u2019s Hospital, and the study was conducted in accordance with the principles of the Helsinki Declaration. Due to the retrospective nature of the data collection, all patient identities were anonymized, and informed consent was waived by the Institutional Review Board of Huai\u2019an No.1 People\u2019s Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1652"}}